Brought to you by 
Series G lands $25mm for EarlySense
Jun 2016
Executive Summary
EarlySense Ltd. (contact-free continuous monitoring solutions) raised $25mm in Series G funding led by Bank Hapoalim, which was joined by Pitango Venture Capital, JK&B Capital, and other previous backers. The company will use the proceeds to drive the growth of its FDA-approved and CE-marked under-mattress sensor devices for tracking heart rate, respiratory rate, and movement.
Deal Industry
-
In Vitro Diagnostics
- Biosensors
-
Medical Devices
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series G lands $25mm for EarlySense
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice